-transparent.png){kind=logo}
We have investigated the relationship between chronic lymphocytic leukemia (CLL), hairy cell leukemia (HCL), and different normal B cell subsets: Mrbc+, T1+ and slgM+ tonsil cells; germinal center; mantle zone; and peripheral blood B lymphocytes. Both malignant and normal cells were incubated in vitro with the phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate (TPA) for 72 hours and the morphology, cytochemical profile, and surface markers were evaluated. The results show that CLL cells TPA-induced become indistinguishable from HCL by four independent criteria: the morphology; the cytoplasmic tartrate resistant acid phosphatase (TRAP) enzyme activity; the membrane positivity with anti-Leu M5 (SHCL3); and anti-Tac monoclonal antibodies which, in the uninduced state, react only with HCL. The features of TRAP and Tac positivity are also expressed (though in variable degree) by different normal B cell populations activated with TPA or pokeweed mitogen (PWM). It is concluded that HCL might represent an aberrantly activated variant of CLL (or of a CLL-related disorder).
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
August 1992,
American journal of hematology,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
November 1982,
Blood,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
January 1986,
Scanning electron microscopy,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
January 1994,
Hematologic pathology,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
April 1986,
Cancer research,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
January 1987,
Blood cells,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
January 1993,
Experimental hematology,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
February 1991,
Current opinion in oncology,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
July 1994,
Current opinion in hematology,
F Caligaris-Cappio, and
G Pizzolo, and
M Chilosi, and
L Bergui, and
G Semenzato, and
L Tesio, and
L Morittu, and
F Malavasi, and
M Gobbi, and
R Schwarting
June 1994,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
